Literature DB >> 22786772

Loss of the oxygen sensor PHD3 enhances the innate immune response to abdominal sepsis.

Judit Kiss1, Martin Mollenhauer, Sarah R Walmsley, Johanna Kirchberg, Praveen Radhakrishnan, Thomas Niemietz, Johanna Dudda, Gunnar Steinert, Moira K B Whyte, Peter Carmeliet, Massimiliano Mazzone, Jürgen Weitz, Martin Schneider.   

Abstract

Hypoxia and HIFs (HIF-1α and HIF-2α) modulate innate immune responses in the setting of systemic inflammatory responses and sepsis. The HIF prolyl hydroxylase enzymes PHD1, PHD2 and PHD3 regulate the mammalian adaptive response to hypoxia; however, their significance in the innate immune response has not been elucidated. We demonstrate in this study that deficiency of PHD3 (PHD3(-/-)) specifically shortens the survival of mice subjected to various models of abdominal sepsis because of an overwhelming innate immune response, leading to premature organ dysfunction. By contrast, this phenotype was absent in mice deficient for PHD1 (PHD1(-/-)) or PHD2 (PHD2(+/-)). In vivo, plasma levels of proinflammatory cytokines were enhanced, and recruitment of macrophages to internal organs was increased in septic PHD3-deficient mice. Reciprocal bone marrow transplantation in sublethally irradiated mice revealed that enhanced susceptibility of PHD3-deficient mice to sepsis-related lethality was specifically caused by loss of PHD3 in myeloid cells. Several in vitro assays revealed enhanced cytokine production, migration, phagocytic capacity, and proinflammatory activation of PHD3-deficient macrophages. Increased proinflammatory activity of PHD3-deficient macrophages occurred concomitantly with enhanced HIF-1α protein stabilization and increased NF-κB activity, and interference with the expression of HIF-1α or the canonical NF-κB pathway blunted their proinflammatory phenotype. It is concluded that impairment of PHD3 enzyme function aggravates the clinical course of abdominal sepsis via HIF-1α- and NF-κB-mediated enhancement of the innate immune response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22786772     DOI: 10.4049/jimmunol.1103471

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

Review 1.  Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases.

Authors:  Vaithinathan Selvaraju; Narasimham L Parinandi; Ram Sudheer Adluri; Joshua W Goldman; Naveed Hussain; Juan A Sanchez; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2013-10-31       Impact factor: 8.401

Review 2.  The regulation of pulmonary inflammation by the hypoxia-inducible factor-hydroxylase oxygen-sensing pathway.

Authors:  Moira K B Whyte; Sarah R Walmsley
Journal:  Ann Am Thorac Soc       Date:  2014-12

3.  Deficiency of the oxygen sensor PHD1 augments liver regeneration after partial hepatectomy.

Authors:  Martin Mollenhauer; Judit Kiss; Johanna Dudda; Johanna Kirchberg; Nuh Rahbari; Praveen Radhakrishnan; Thomas Niemietz; Vanessa Rausch; Jürgen Weitz; Martin Schneider
Journal:  Langenbecks Arch Surg       Date:  2012-09-11       Impact factor: 3.445

4.  Editorial: a PHD in macrophage survival.

Authors:  Cormac T Taylor; Carsten C Scholz
Journal:  J Leukoc Biol       Date:  2014-09       Impact factor: 4.962

5.  Immunologic Consequences of Hypoxia during Critical Illness.

Authors:  Harmke D Kiers; Gert-Jan Scheffer; Johannes G van der Hoeven; Holger K Eltzschig; Peter Pickkers; Matthijs Kox
Journal:  Anesthesiology       Date:  2016-07       Impact factor: 7.892

6.  CITED2 Restrains Proinflammatory Macrophage Activation and Response.

Authors:  Gun-Dong Kim; Riku Das; Xiaoquan Rao; Jixin Zhong; Jeffrey A Deiuliis; Diana L Ramirez-Bergeron; Sanjay Rajagopalan; Ganapati H Mahabeleshwar
Journal:  Mol Cell Biol       Date:  2018-02-12       Impact factor: 4.272

Review 7.  Vascular endothelial growth factor signaling in hypoxia and inflammation.

Authors:  S Ramakrishnan; Vidhu Anand; Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2014-03-09       Impact factor: 4.147

Review 8.  Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD.

Authors:  Sophie Van Welden; Andrew C Selfridge; Pieter Hindryckx
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-30       Impact factor: 46.802

Review 9.  Hypoxia-dependent regulation of inflammatory pathways in immune cells.

Authors:  Cormac T Taylor; Glen Doherty; Padraic G Fallon; Eoin P Cummins
Journal:  J Clin Invest       Date:  2016-07-25       Impact factor: 14.808

Review 10.  Redox control of inflammation in macrophages.

Authors:  Bernhard Brüne; Nathalie Dehne; Nina Grossmann; Michaela Jung; Dmitry Namgaladze; Tobias Schmid; Andreas von Knethen; Andreas Weigert
Journal:  Antioxid Redox Signal       Date:  2013-03-06       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.